SCHEMBL25823853

SCHEMBL25823853

CC(CC1CCN(C(C)CC2CCN2C(C)C)C1)N1CCOCC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26820737 0.89 MEN1 (0.34) MEN1KMT2A
SCHEMBL18697407 0.86
SCHEMBL20755508 0.84 MEN1 (0.36) MEN1KMT2A
SCHEMBL23513066 0.83
SCHEMBL24951509 0.81 MEN1 (0.33) MEN1KMT2A
SCHEMBL21993492 0.80
SCHEMBL18971793 0.76 MEN1 (0.32) MEN1KMT2A
SCHEMBL19788364 0.76 MEN1 (0.35) MEN1KMT2A
SCHEMBL19730586 0.74
SCHEMBL25834408 0.74 HRH3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MEN1 1948/4885KMT2A 3974/4885
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA MEN1 1172/4885KMT2A 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.